ATE212036T1 - Lactol-derivate, als cathepsin l inhibitoren - Google Patents

Lactol-derivate, als cathepsin l inhibitoren

Info

Publication number
ATE212036T1
ATE212036T1 AT94113669T AT94113669T ATE212036T1 AT E212036 T1 ATE212036 T1 AT E212036T1 AT 94113669 T AT94113669 T AT 94113669T AT 94113669 T AT94113669 T AT 94113669T AT E212036 T1 ATE212036 T1 AT E212036T1
Authority
AT
Austria
Prior art keywords
group
substituted
cathepsin
acyl group
esterified
Prior art date
Application number
AT94113669T
Other languages
English (en)
Inventor
Takashi Sohda
Yukio Fujisawa
Satoru Oi
Junji Mizoguchi
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE212036T1 publication Critical patent/ATE212036T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043Leu-amino acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pyrane Compounds (AREA)
  • Saccharide Compounds (AREA)
AT94113669T 1993-09-03 1994-09-01 Lactol-derivate, als cathepsin l inhibitoren ATE212036T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP21965593 1993-09-03
JP16850194 1994-07-20
JP19038594 1994-08-12

Publications (1)

Publication Number Publication Date
ATE212036T1 true ATE212036T1 (de) 2002-02-15

Family

ID=27323012

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94113669T ATE212036T1 (de) 1993-09-03 1994-09-01 Lactol-derivate, als cathepsin l inhibitoren

Country Status (12)

Country Link
US (1) US5496834A (de)
EP (1) EP0641800B1 (de)
KR (1) KR950008497A (de)
CN (1) CN1106001A (de)
AT (1) ATE212036T1 (de)
AU (1) AU678493B2 (de)
CA (1) CA2131397A1 (de)
DE (1) DE69429642T2 (de)
FI (1) FI944040A7 (de)
HU (1) HUT68717A (de)
NO (1) NO943210L (de)
NZ (1) NZ264376A (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW394764B (en) * 1995-02-14 2000-06-21 Mitsubishi Chemcal Corp Oxygen-containing heterocyclic derivatives
US20030096760A1 (en) * 1997-03-10 2003-05-22 Smithklinebeecham Corporation Method of antagonizing the human SRC SH2 domain
FR2800737B1 (fr) * 1999-11-05 2006-06-30 Sod Conseils Rech Applic Nouveaux composes heterocycliques et leur application a titre de medicaments
ATE318809T1 (de) * 1999-11-05 2006-03-15 Sod Conseils Rech Applic Heterocyclische verbindungen und ihre verwendung als medikamente
US6720327B2 (en) 2000-09-27 2004-04-13 Pharmacia Corporation Lactone integrin antagonists
DE10124041A1 (de) * 2001-05-16 2002-11-21 Graffinity Pharm Design Gmbh Protease Inhibitoren
US7202274B2 (en) 2002-03-15 2007-04-10 Senju Pharmaceutical Co., Ltd. Cyclic hemiacetal derivative and use thereof
WO2005033068A1 (en) * 2003-10-06 2005-04-14 Oy Juvantia Pharma Ltd Somatostatin receptor 1 and/or 4 selective agonists and antagonists
US20070203073A1 (en) * 2005-06-22 2007-08-30 Diamond Scott L SARS and Ebola inhibitors and use thereof, and methods for their discovery
KR20240035513A (ko) 2021-07-09 2024-03-15 알리고스 테라퓨틱스 인코포레이티드 항바이러스 화합물
US12065428B2 (en) 2021-09-17 2024-08-20 Aligos Therapeutics, Inc. Anti-viral compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0504938A3 (en) * 1991-03-22 1993-04-14 Suntory Limited Prophylactic and therapeutic agent for bone diseases comprising di- or tripeptide derivative as active ingredient
EP0519748B1 (de) * 1991-06-21 1998-09-02 Merck & Co. Inc. Peptidylderivate als Inhibitoren von Interleukin-1B-konvertierenden Enzymen

Also Published As

Publication number Publication date
FI944040A7 (fi) 1995-03-04
EP0641800B1 (de) 2002-01-16
FI944040A0 (fi) 1994-09-02
CN1106001A (zh) 1995-08-02
NO943210D0 (no) 1994-08-30
EP0641800A1 (de) 1995-03-08
DE69429642T2 (de) 2002-09-12
US5496834A (en) 1996-03-05
NO943210L (no) 1995-03-06
CA2131397A1 (en) 1995-03-04
AU678493B2 (en) 1997-05-29
HUT68717A (en) 1995-07-28
DE69429642D1 (de) 2002-02-21
KR950008497A (ko) 1995-04-17
NZ264376A (en) 1996-03-26
HU9402536D0 (en) 1994-10-28
AU7168294A (en) 1995-03-16

Similar Documents

Publication Publication Date Title
US5889009C1 (en) Method of inhibiting cell adhesion
WO1996016079A3 (en) Alpha-ketoamide derivatives as cathepsin l inhibitor
ZA971714B (en) Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
IL135536A0 (en) Ortho-anthranilamide derivatives and pharmaceutical compositions containing the same
DE69432614D1 (de) Alkohol und Aldehyde Derivate als Cathepsin L Inhibitore und als Inhibitore der Knochenresorption
GR3032311T3 (en) Stilbene derivatives and pharmaceutical compositions containing them
DK0659174T3 (da) Derivater af valproinsyre og 2-valproensyreamider samt deres anvendelse som antikonvulsive midler
KR970704864A (ko) 세정제 조성물
ATE212036T1 (de) Lactol-derivate, als cathepsin l inhibitoren
NZ279397A (en) Mercaptoacetylamido 1,3,4,5-tetrahydro-benzo[c]azepin-3-one disulfide derivatives and pharmaceutucal compositions
ES2103027T3 (es) Derivados de tienopiridina y composiciones farmaceuticas que los contienen.
TW256832B (de)
DK656789A (da) Benzoheterocykliske forbindelser
DK0460488T3 (da) Svovlholdige heterocykliske forbindelser
KR950011429A (ko) 에폭시숙신산 유도체
DK0668279T3 (da) 6-azaindol thromboxansytaseinhibitor
IL108856A0 (en) Hydroxymethyl-furazancarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them
IL112630A0 (en) Indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors or enkephalinase
BR9901201A (pt) Composto de titanato
ATE122683T1 (de) Epoxybernsteinsäurederivate, verwendbar als spezifische hemmer von cathepsin b.
IT1313623B1 (it) Uso di carbonati organici come solventi per il lavaggio di superficimetalliche
RU94031748A (ru) Производные лактола, способы их получения, фармацевтические композиции
HUT67475A (en) Benzene derivatives and pharmaceutical compositions containing them as active components
IT1263959B (it) N-acil-peptidi inibitori delle protein-chinasi

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties